Endocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Horm Res Paediatr. 2020;93(6):396-401. doi: 10.1159/000510462. Epub 2020 Oct 9.
Mutations of the insulin receptor (INSR) gene lead to a wide spectrum of inherited insulin resistance (IR) syndromes. Among these, type A-IR, usually caused by dominant negative INSR mutations, generally presents peri-pubertally in girls.
A 2.8-year-old girl was referred due to recurrent postprandial and fasting hypoglycemia. She had been born at full-term with birth weight 1.89 kg, and had developed transient neonatal diabetes. Examination showed satisfactory growth, reduced adipose tissue, acanthosis nigricans, and isolated thelarche. After 12 h of fasting, she developed hypoglycemia (glucose 2.8 mmol/L), with inappropriately raised plasma insulin concentration of 5.4 mU/L and suppressed fatty acids and ketone bodies. Oral glucose tolerance testing showed severely increased plasma insulin concentration (>300 mU/L) with hypoglycemia (glucose 1.6 mmol/L) at 2.5 h. She was initially managed on dietary modifications, cornstarch, and then trialed on acarbose for postprandial hyperinsulinemic hypoglycemia (PPHH) with some response. However, she was noted to have increased frequency of hyperglycemia after a couple of years of treatment. She was then switched to metformin and continued to have dietary carbohydrate modification including cornstarch that improved fasting tolerance, hyperglycemia, and postprandial hypoglycemia. Genetic testing identified heterozygous deletion of the last exon of the INSR gene, exon 22.
We present a case of type A-IR, caused by a novel INSR deletion, presenting unusually early with transient neonatal diabetes, followed by episodes of hypoglycemia and hyperglycemia during later childhood. Early life presentations, including neonatal diabetes and PPHH, should lead to consideration of type A-IR.
胰岛素受体(INSR)基因突变导致广泛的遗传性胰岛素抵抗(IR)综合征。其中,A 型-IR 通常由显性负性 INSR 突变引起,通常在女孩青春期前表现出来。
一名 2.8 岁女孩因反复餐后和空腹低血糖就诊。她足月出生,体重 1.89kg,曾患有短暂性新生儿糖尿病。检查发现生长良好,脂肪组织减少,黑棘皮病,孤立性性早熟。禁食 12 小时后,她出现低血糖(血糖 2.8mmol/L),血浆胰岛素浓度不适当升高(5.4mU/L),脂肪酸和酮体被抑制。口服葡萄糖耐量试验显示,在 2.5 小时时出现严重的高胰岛素血症(>300mU/L)和低血糖(血糖 1.6mmol/L)。她最初通过饮食调整、玉米淀粉进行治疗,然后试用阿卡波糖治疗餐后高胰岛素血症性低血糖(PPHH),有一定的疗效。然而,几年后,她出现了更高的血糖频率。随后她改用二甲双胍,继续进行饮食碳水化合物调整,包括玉米淀粉,这改善了空腹耐受性、高血糖和餐后低血糖。基因检测发现 INSR 基因的最后一个外显子(外显子 22)杂合缺失。
我们报告了一例由 INSR 缺失引起的 A 型-IR 病例,其表现异常早,伴有短暂性新生儿糖尿病,随后在儿童后期出现低血糖和高血糖发作。新生儿糖尿病和 PPHH 等早期表现应考虑 A 型-IR。